HIV and hepatitis B co-infection - prevalence and clinical spectrum in a rural tertiary care centre of Northern India

Ranjit Kumar Nim, Vivek Kumar Verma, Manoj Kumar, Dheeraj Kela, Brijesh Singh, Neetu Singh, Anand Kumar Singh, Sushil Kumar


Background: HBV and HIV are both endemic in India. Currently, it is not well established what proportion of HIV-positive patients harbours HBV infection in India. No study was done to know the epidemiology of HBV HIV Co infection in rural population of Northern India. So, this study was done to explore the impact of HBV in HIV patients.

Methods: Prospective cohort study was conducted on HIV-HBV co infected patients who attended the ART Clinic at ART centre, Department of Medicine, UPUMS, Saifai, Etawah, after obtaining informed consent.

Results: Out of these 1751 HIV patients 919 were eligible for start on ART and the remaining were treatment naïve patients. Out of these 1751 HIV positive patients 79 patients were HBS Ag positive. Thus, the prevalence of HBV-HIV co infection at our ART centre was found to be around 4.5%. 68 patients were found to be eligible for start of ART drugs. Out of these 68 patients on ART, 46 (67.6%) patients were alive, 9 (13.2%) were transferred out, 5 (7.4%) patients were lost to follow up (LFU) and 8 (11.8%) expired till the end of the study.

Conclusions: HBV co infection is common in HIV serology positive and can cause significant morbidity and mortality especially in the presence of other concurrent cause of liver injury. HBV co infection might associate with severe hepatotoxicity during intake of HAART regimen. For these reasons, prevention and treatment of HBV infection is mandatory in HIV serology positive.



Full Text:



Yeni PG, Hammer SM, Carpenter CJ, Cooper DA, Fischl MA, Gatell JM, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the international aids society-USA panel. JAMA. 2002;288(2):222-35.

Kobayashi S, Ide T, Sata M. Detection of YMDD motif mutations in some lamivudine-untreated asymptomatic hepatitis B virus carriers. J Hepatol. 2001;34(4):584-6.

Ohishi W, Shiakawa H, Kawakami Y, Kimura S. Identification of rare polymerase variants of hepatitis B virus using a two-stage PCR with peptide nucleic acid clamping. J Med Virol. 2004;72:558-65.

Selabe SG, Lukhwareni A, Song E, Leuw YG, Burnett RJ, Mphahlele MJ. Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV coinfection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients. J Med Virol. 2007;79(11):1650-4.

Soriano V, Puoti M, Bonacini M. Care of patients with chronic hepatitis B and HIV coinfection: recommendations from an HIVHBV international panel. AIDS. 2005;19:221-40.

Gatanaga H, Bazooka A, Kikuchi Y, Tatiana N, Oak S. Influence of prior HIV-1 infection on the development of chronic hepatitis B infection. Eur Jf Clin Microbiol Infectious Disease. 1997;19:237-9.

Colin JF, Cazals‐Hatem D, Loriot MA, Martinot‐Peignoux M, Pham BN, Auperin A, et al. Influence of HIV infection on chronic hepatitis B in homosexual men. Hepatol. 1999;29:1306-10.

Soriano V, Puoti M, Bonacini M. Care of patients with chronic hepatitis B and HIV coinfection:recommendations from an HIVHBV international panel. AIDS. 2005;19:221-40.

Gupta, Singh S. HBV-HIV coinfection. BMC infection Dis. 2010;10(53):53

Tripathi AK. AIDS care and ART Centre KGMC, Lucknow. J Assoc Physican India. 2007;55:429-31.

Alter MJ. Centre of disease control and prevention Mails top, Atlanta. 2006;44:6-9.

Arora U. Department of Microbiology Government Medical College Amritsar, 2007.

Gupta, Singh S. North Indian Study. World J Gastroentrology. 2006;12(42):6879-83

Hoffmann CJ, Thio CL. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infectious Diseases. 2007;7(6):402-9.

Kumarasamy N, Vallabhaneni S, Flanigan TP, Mayer KH, Solomon S. Clinical Profile of HIV in India. IJMR. 2005;121:377-94.

Lewden C, Salmon D, Morlat P, Bevilacqua S, Jougla E, Bonnet F, et al. Causes of death among human immunodeficiency virus (HIV)- infected adults in the era of potent antiretroviral therapy: emerging role of hepatitis and cancers, persistent role of AIDS. Int J Epidemiol. 2005;34:121-30.

Pogany K. AIDS Research and Human Retroviruses. 2005;(2):922-96.

British HIV Association Guidelines for Treatment of HIV-1, 2008.

Heo J, Cho M, Kim HH, Shin YM, Jang HJ, Park HK, et al. Detection of YMDD motif mutants by oligonucleotide chips in lamivudine-untreated patients with chronic HBV infection. J Korean Med Sci. 2004;19:541-546.